13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001882053
Total reported value
$427.5M
$427.5M
13 檔
42.1%
The Q4 2024 SEC filing reveals that Boone Capital Management LLC held a total portfolio value of $427.5M, covering 13 public equity positions.
In Q4 2024, Boone Capital Management LLC adopted a defensive or profit-taking posture, trimming 5 positions and completely liquidating 6 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | UNM | Unum Group | Stock-Financials | 19.80% | — | -16.63% | |
| 2 | GMED | Globus Medical Inc - A | Stock-Healthcare | 15.86% | — | -12.77% | |
| 3 | PRGO | Perrigo Company plc | Stock-Healthcare | 8.87% | — | +126.08% | |
| 4 | MIRM | Mirum Pharmaceuticals Inc | Stock-Other | 8.12% | -0.54% | +6.99% | |
| 5 | MOH | Molina Healthcare Inc | Stock-Healthcare | 8.03% | — | +14.14% | |
| 6 | CI | THE Cigna Group | Stock-Healthcare | 8.00% | -0.97% | -34.92% | |
| 7 | OFIX | Orthofix Medical Inc | Stock-Other | 6.23% | — | +13.63% | |
| 8 | PNTG | Pennant Group Inc/the | Stock-Other | 5.74% | +4.46% | NEW | |
| 9 | BHVN | Biohaven Ltd. | Stock-Other | 4.55% | — | — | |
| 10 | IDYA | Ideaya Biosciences Inc | Stock-Other | 4.55% | — | -1.27% | |
| 11 | IQV | Iqvia Holdings Inc | Stock-Healthcare | 3.79% | — | -15.45% | |
| 12 | GNW | Genworth Financial Inc | Stock-Financials | 3.62% | — | — | |
| 13 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 2.85% | — | +8.79% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | PRGO | Perrigo Company plc | +5.8% | +126.08% | Add |
| 2 | UNM | Unum Group | +4.9% | -16.63% | Trim |
| 3 | BHVN | Biohaven Ltd. | +4.6% | NEW | New buy |
| 4 | GMED | Globus Medical Inc - A | +3.8% | -12.77% | Trim |
| 5 | GNW | Genworth Financial Inc | +3.6% | NEW | New buy |
| 6 | MIRM | Mirum Pharmaceuticals Inc | +2.6% | +6.99% | Add |
| 7 | OFIX | Orthofix Medical Inc | +2.5% | +13.63% | Add |
| 8 | MOH | Molina Healthcare Inc | +1.6% | +14.14% | Add |
| 9 | IDYA | Ideaya Biosciences Inc | +0.2% | -1.27% | Trim |
| 10 | PNTG | Pennant Group Inc/the | -0.2% | — | Unchanged |
| 11 | VKTX | Viking Therapeutics Inc | -0.3% | +8.79% | Add |
| 12 | IQV | Iqvia Holdings Inc | -0.4% | -15.45% | Trim |
| 13 | CERT | Certara Inc | -1.6% | EXIT | Sold out |
| 14 | CI | THE Cigna Group | -3.9% | -34.92% | Trim |
| 15 | AMPH | Amphastar Pharmaceuticals In | -4% | EXIT | Sold out |
| 16 | BERYEUR | Berry Global Group Inc | -4.3% | EXIT | Sold out |
| 17 | BAX | Baxter International Inc | -4.4% | EXIT | Sold out |
| 18 | DHR | Danaher CORP | -4.4% | EXIT | Sold out |
| 19 | CHE | Chemed CORP | -6.1% | EXIT | Sold out |
According to official SEC Form 13F filings, Boone Capital Management LLC reported a total U.S. public equity portfolio value of $427.5M across 13 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including UNM, GMED, PRGO) accounted for 42.1% of total reported equity market value during Q4 2024.
Top New Position Initiated
BHVN
市值: $13.5M
Top Position Liquidated / Trimmed
CHE
前期市值: $23.7M
During Q4 2024, Boone Capital Management LLC's top holdings by market value included UNM (19.8%)、GMED (15.9%)、PRGO (8.9%). The largest single position, UNM, represented 19.8% of total portfolio value.
In Q4 2024, Boone Capital Management LLC made 18 total portfolio adjustments, initiating 2 new buys, adding to 5 positions, trimming 5 holdings, and fully liquidating 6 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.